VIM and breast carcinoma: Besides, the increase phenotype in invasive capacity of MDA-MB-231 by overexpression of p62 is dependent on Vimentin levels, demonstrating Vimentin plays a crucial role in p62-mediated invasion in breast cancer cells (71).